Tevogen Bio Holdings Inc. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$-196K
R&D
$11M
D&A
$191K
Operating Income
$-26M
EBITDA
$-26M
Interest Expense
$184K
Interest Income
—
Tax Provision
$5K
Net Income
$-26M
Operating Margin
13363.0%
Net Margin
13432.0%
Deferred Tax Assets
$372K
DTA Valuation Allowance
$19M
NOL Carryforwards
$11M
ETR Federal Statutory
21.0%
ETR State + Local (pp)
1.0%
Operating Lease Cost
$1M
Revenue YoY Variation
-6.3%
Income YoY Variation
51.2%